Alexion Pharmaceuticals (ALXN)

Add to Watchlists
Create an Alert
125.15 -0.92  -0.73% NASDAQ Jun 26, 16:59 Delayed 2m USD

Alexion Pharmaceuticals Revenue (TTM):

3.253B for March 31, 2017
View 4,000+ financial data types
Browse...
View Full Chart

Alexion Pharmaceuticals Revenue (TTM) Chart

Export Data
Save Image
Print Image

Alexion Pharmaceuticals Historical Revenue (TTM) Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 3.253B
Dec. 31, 2016 3.084B
Sept. 30, 2016 2.954B
June 30, 2016 2.822B
March 31, 2016 2.705B
Dec. 31, 2015 2.604B
Sept. 30, 2015 2.503B
June 30, 2015 2.391B
March 31, 2015 2.268B
Dec. 31, 2014 2.234B
Sept. 30, 2014 2.076B
June 30, 2014 1.921B
March 31, 2014 1.779B
Dec. 31, 2013 1.551B
Sept. 30, 2013 1.430B
June 30, 2013 1.324B
March 31, 2013 1.228B
Dec. 31, 2012 1.134B
Sept. 30, 2012 1.041B
June 30, 2012 951.06M
March 31, 2012 862.04M
Dec. 31, 2011 783.43M
Sept. 30, 2011 711.85M
June 30, 2011 649.37M
March 31, 2011 589.50M
   
Dec. 31, 2010 540.96M
Sept. 30, 2010 495.63M
June 30, 2010 456.69M
March 31, 2010 423.11M
Dec. 31, 2009 386.80M
Sept. 30, 2009 353.55M
June 30, 2009 327.42M
March 31, 2009 294.72M
Dec. 31, 2008 259.10M
Sept. 30, 2008 215.56M
June 30, 2008 161.17M
March 31, 2008 111.36M
Dec. 31, 2007 72.04M
Sept. 30, 2007 38.37M
June 30, 2007 16.52M
March 31, 2007 7.107M
Dec. 31, 2006 1.558M
Sept. 30, 2006 1.935M
June 30, 2006 1.62M
March 31, 2006 1.665M
Oct. 31, 2005 1.46M
July 31, 2005 1.042M
April 30, 2005 5.241M
Jan. 31, 2005 5.025M
Oct. 31, 2004 4.609M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

ALXN Revenue (TTM) Benchmarks

Companies
Incyte 1.226B
Coherus BioSciences 177.91M
Parexel International 2.419B

ALXN Revenue (TTM) Range, Past 5 Years

Minimum 951.06M Jun 2012
Maximum 3.253B Mar 2017
Average 2.063B

ALXN Revenue (TTM) Excel Add-In Codes

  • Metric Code: revenues_ttm
  • Latest data point: =YCP("ALXN", "revenues_ttm")
  • Last 5 data points: =YCS("ALXN", "revenues_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.